Athan Kuliopulos MD, PhD

Dr. Athan Kuliopulos, MD, Ph.D. is an Chief Executive Officer at Oasis Pharmaceuticals. He received a Doctor of Medicine from The Johns Hopkins Medical School. His research interests are Oncology, Hematology Blood and Marrow Transplant, Biochemistry and Molecular Genetics, Fibrotic-inflammatory Diseases.